drugset / Trial / NCT00002402

A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines

NCT00002402

Phase 1 Completed 120 enrolled VaxGen
Prevention

Summary

The purpose of this study is to see if it is safe and effective to give AIDSVAX B/B or AIDSVAX B/E, two potential HIV vaccines, to HIV-negative volunteers.

Timeline

Start
Primary completion
Completion

Publications

  • Background Mayer K, Judson F, Gorse G, Harro C, Peterson M, Zaharias E, Good J, Shibata R, Lee S, Eastman D, Chernow M, Francis D, Berman P. A phase I/II trial to evaluate the safety and immunogenicity of the AIDSVAX B/B vaccine in the United States (final report). 8th Conf Retro and Opportun Infect. 2001 Feb 4-8 (abstract no 178)

Drugs

EvaluationDrugModalityDoseRoute
Subject AIDSVAX B/B Unknown Intramuscular
Subject AIDSVAX B/E Unknown Intramuscular
Background Aluminum hydroxide Unknown